CD274 and neoplasm: Biomarkers for lung cancer prediction and prognosis include PD-L1 (programmed death-ligand 1) expression, tumor mutation burden (TMB), tumor-infiltrating lymphocytes, LIPI (Lung Immune Prognostic Index), microsatellite instability, etc., though commonly used, lack unified detection standards5.